Michael Brucculeri is a Nephrology physician affiliated with University of South Florida. OpenAlex indexes 11 publications with 281 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1055 S Fort Harrison Ave
Clearwater, FL 337563905
Telephone
727-442-6245Registry record last updated 9 Feb 2016.
Industry payments
25 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Fresenius USA Marketing, Inc.Program year20255 payments
- Novo Nordisk IncProgram year20254 payments
- Otsuka America Pharmaceutical, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
44.8%Calcium channel blocker7.8%Nifedipine Er52%Amlodipine Besylate44%Diltiazem 24hr Er (Cd)2%Amlodipine Besylate-Benazepril2%Part D<11 patientsAngiotensin receptor blocker (ARB)7.7%Losartan Potassium36%Valsartan28%Olmesartan Medoxomil8%Irbesartan8%Valsartan-Hydrochlorothiazide7%Candesartan Cilexetil5%Telmisartan5%Losartan-Hydrochlorothiazide3%Part D<11 patients+ 16 more classes in this area
Metabolism & gastrointestinal
28%Vitamin D3 Analog15.6%Calcitriol100%Part D≥417 patientsPotassium supplement3.7%Potassium Chloride93%Klor-Con M207%Part D<11 patients+ 10 more classes in this area
Musculoskeletal
8.9%Xanthine oxidase inhibitor8.6%Allopurinol87%Febuxostat13%Part D≥196 patientsAlkaloid0.3%Colchicine100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Potassium wasting nephropathy in the setting of tizanidine overdose: a case report
Journal of Medical Case Reports
2021 - Simultaneous Double Hemodialysis for the Control of Refractory Hyperammonemia
The International Journal of Artificial Organs
2013 - Role of sodium thiosulfate therapy in the treatment of digital necrosis due to <scp>M</scp>önckeberg sclerosis
Hemodialysis International
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Vogelbaum, MD
University of South Florida
Thomas Casale, MD
University of South Florida
Richard Lockey, MD
University of South Florida
Robert Hauser, MD
University of South Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”